Search results
AstraZeneca is pulling its COVID-19 vaccine
Quartz· 12 hours agoCambridge, U.K.-based pharma giant AstraZeneca said on Wednesday that it is no longer producing or supplying its COVID-19 vaccine, known as Vaxzeveria,...
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
NBC Philadelphia· 7 days agoModerna posted a narrower-than-expected loss for the first quarter as the company's cost-cutting...
Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y
Zacks via Yahoo Finance· 7 days agoModerna, Inc. MRNA reported earnings of $3.07 per share in the first quarter of 2024, beating the...
Why Moderna Stock Blasted 13% Higher Today
Motley Fool via Yahoo Finance· 6 days agoModerna (NASDAQ: MRNA) was a fine stock to heal an ailing portfolio on the second-to-last trading day of the week. The company, which developed and sells...
Moderna ends gene editing alliance with Metagenomi
BioPharma Dive via Yahoo Finance· 7 days agoMetagenomi said the companies’ decision to part ways followed a “strategic prioritization” undertaken by Moderna, which has made several investments in...
Check Out What Whales Are Doing With MRNA - Moderna (NASDAQ:MRNA)
Benzinga· 2 days agoLoading... Loading... Deep-pocketed investors have adopted a bullish approach towards Moderna MRNA , and it's something market players shouldn't ignore. Our tracking of public ...
Royal Bank of Canada Increases Moderna (NASDAQ:MRNA) Price Target to $135.00
ETF DAILY NEWS· 4 days agoModerna (NASDAQ:MRNA – Get Free Report) had its target price lifted by Royal Bank of Canada from $125.00 to $135.00 in a report issued on Friday, Benzinga reports. Royal Bank ...
Will withdrawal of AstraZeneca vaccine affect your next COVID booster jab?
Yahoo News UK· 15 hours agoAppointments were offered from April and UK Health Security Agency advice on bookings set out the...
Moderna reports $1.2bn net loss in Q1 2024
Pharmaceutical Technology via Yahoo Finance· 6 days agoModerna experienced a substantial financial shift in the first quarter (Q1) of 2024, reporting a net loss of $1.2bn - a stark contrast to its net income...
Moderna expects CDC to view its RSV vaccine as equal to rival shots
Reuters· 7 days ago, opens new tab said on Thursday it expects U.S. Center for Disease Control and Prevention (CDC)...
